Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fibrin patch - Ethicon/Omrix Biopharmaceuticals

Next Previous
Drug Profile

Fibrin patch - Ethicon/Omrix Biopharmaceuticals

Alternative Names: Evarrest; Fibrin pad; Fibrin sealant patch

Latest Information Update: 12 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ethicon; OMRIX Biopharmaceuticals
  • Class Antihaemorrhagics; Blood coagulation factors; Blood proteins; Serine endopeptidases
  • Mechanism of Action Fibrin stimulants; Thrombin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Surgical blood loss

Most Recent Events

  • 27 Aug 2019 Phase III development is ongoing in Australia, Japan, New Zealand, USA and United Kingdom (Ethicon pipeline, August 2019)
  • 05 Mar 2016 Phase-III clinical trials in Surgical blood loss (In adolescents, In children, In infants, In neonates) in England before March 2016 (Perilesional)
  • 05 Mar 2016 Efficacy data from a phase III trial in Surgical blood loss released by Ethicon

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top